Advancements in pulmonary alveolar proteinosis treatment: A journey from discovery to GM-CSF inhalation therapy

Respir Investig. 2024 May;62(3):375-376. doi: 10.1016/j.resinv.2024.02.013. Epub 2024 Mar 3.

Author

Takuro Sakagami¹

Affiliation

¹ Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan. Electronic address: stakuro@kumamoto-u.ac.jp.

PMID: 38437758
DOI: 10.1016/j.resinv.2024.02.013

No abstract available

Publication types

Editorial

MeSH terms

Administration, Inhalation
Autoantibodies
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
Humans
Pulmonary Alveolar Proteinosis* / drug therapy
Respiratory Therapy

Substances

Granulocyte-Macrophage Colony-Stimulating Factor
Autoantibodies